Galectin Therapeutics Inc. appointed Benjamin S. Carson, Sr., M.D. as a new member of the Board of Directors, following his service as a senior advisor to the Company since 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 USD | -1.50% |
|
+0.77% | +57.83% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.83% | 163M | |
+40.80% | 53.67B | |
+34.46% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- GALT Stock
- News Galectin Therapeutics Inc.
- Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors